Sign inJoin waitlistJoin the waitlist

Walid Shaib

Affiliate · Wellstar Health System

Credentials: · · · · ·

History

Wellstar Health System
Present

Hematology and Medical Oncology
Emory University School of Medicine
2011–2014
Internal Medicine
Univ of Connecticut Health Center/John Dempsey Hospital
2005–2008
American University - Beirut Emory University
2001–2005

Research

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Review · British Journal of Cancer · 2019 · 320 citations
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
British Journal of Cancer · 2019 · Last of 19 authors · 288 citations
Appendiceal Mucinous Neoplasms: Diagnosis and Management
Review · The Oncologist · 2017 · First of 9 authors · Corresponding · 176 citations

Bassel El-Rayes
62 papers
Olatunji Alese
43 papers · 2 as a fellow
Christina Wu
41 papers
Mehmet Akce
37 papers
KZ
Katerina Zakka
20 papers · 10 as a resident
Shishir Maithel
12 papers
Suresh Ramalingam
10 papers
Taofeek Owonikoko
9 papers
David Kooby
8 papers
Mehmet Bilen
8 papers
Bradley Carthon
7 papers
Conor Steuer
7 papers

Clinical trials

Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
Principal investigator · Withdrawn · Phase 2
Walid Shaib, MD
2021–2023
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Principal investigator · Completed · Phase 2
Walid Shaib, MD
2016–2022